Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in plasma of GBM patients, we performed quantitative comparisons of the plasma proteomes of GBM patients (n = 14) and healthy controls (n...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Miyauchi, Eisuke, Furuta, Takuya, Ohtsuki, Sumio, Tachikawa, Masanori, Uchida, Yasuo, Sabit, Hemragul, Obuchi, Wataru, Baba, Tomoko, Watanabe, Michitoshi, Terasaki, Tetsuya, Nakada, Mitsutoshi
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841790/
https://ncbi.nlm.nih.gov/pubmed/29513714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193799
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items